Loading

http://scholar.google.co.uk/scholar_url?url=http://onlinelibrary.wiley.com/doi/10.1111/irv.12346/pdf&hl=en&sa=X&scisig=AAGBfm1bb529k7iHgj_Cu2G-l6VC4rVLRg&nossl=1&oi=scholaralrt

Elevated IL-3 and IL-12p40 levels in the lower airway of infants with RSV-induced bronchiolitis correlate with recurrent wheezing — ScienceDirect

http://www.sciencedirect.com/science/article/pii/S1043466615300272

ERJ | Mobile

http://m.erj.ersjournals.com/content/early/2015/08/20/13993003.00587-2015.abstract


Thanks

Stool screening of Syrian refugees and asylum seekers in Germany, 2013/2014: Identification of Sabin like polioviruses — ScienceDirect

http://www.sciencedirect.com/science/article/pii/S1438422115000715

Favorites

http://onlinelibrary.wiley.com/store/10.1111/irv.12346/asset/irv12346.pdf;jsessionid=0D88653EAE9F2DEE9FA6BC36B5382D7A.f02t02?v=1&t=idqyyq09&s=854904bbb62cc5c43aa105094a1717c0c771db70

Vaccine for Mers 'looks promising'

Vaccine for Mers 'looks promising'
BBC NEWS - HEALTH | 20 AUGUST 2015
http://pulse.me/s/4tJG1d
A prototype vaccine against the lung infection MERS coronavirus shows promising results, scientists say. Read more

Posted by Rob Lambkin-Williams

Visterra Announces Publication of Data Demonstrating the Effectiveness of VIS410 Against Seasonal and Potential Pandemic Influenza Strains - FierceBiotech

http://www.fiercebiotech.com/press-releases/visterra-announces-publication-data-demonstrating-effectiveness-vis410-agai

Posted by Rob Lambkin-Williams

Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion F Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine

http://jvi.asm.org/content/early/2015/07/24/JVI.01380-15.abstract

Posted by Rob Lambkin-Williams

Assessing coughing-induced influenza droplet transmission and implications for infection risk... - Abstract - Europe PubMed Central

http://europepmc.org/abstract/med/26211781


Posted by Rob Lambkin-Williams

Novavax (NVAX) Announces Seasonal Influenza VLP Met Immunogenicity Targets in ... - StreetInsider.com

Novavax (NVAX) Announces Seasonal Influenza VLP Met Immunogenicity Targets in ... - StreetInsider.com
INFLUENZA - GOOGLE NEWS | 30 JULY 2015
http://pulse.me/s/4pZqRU
Novavax (NVAX) Announces Seasonal Influenza VLP Met Immunogenicity Targets in ...StreetInsider.comNovavax (NASDAQ: NVAX) ... Read more

Posted by Rob Lambkin-Williams